Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
18.14
-0.44 (-2.37%)
At close: Mar 6, 2026, 4:00 PM EST
18.32
+0.18 (0.99%)
After-hours: Mar 6, 2026, 6:19 PM EST
Pulse Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.35 | - | - | 0.7 | 1.42 | |
| Revenue Growth (YoY) | - | - | - | -50.63% | - | |
| Cost of Revenue | 0.54 | - | - | 11.94 | 1.97 | |
| Gross Profit | -0.19 | - | - | -11.24 | -0.55 | |
| Selling, General & Admin | 32.03 | 23.92 | 15.78 | 25.97 | 33.82 | |
| Research & Development | 44.72 | 32.34 | 27.8 | 20.84 | 28.64 | |
| Operating Expenses | 76.75 | 56.26 | 43.57 | 46.81 | 62.46 | |
| Operating Income | -76.94 | -56.26 | -43.57 | -58.06 | -63.01 | |
| Interest Expense | - | - | -1.1 | -0.9 | -0.7 | |
| Interest & Investment Income | 4.21 | 2.69 | 2.46 | 0.64 | 0.05 | |
| Other Non Operating Income (Expenses) | -0.05 | -0.02 | - | - | - | |
| EBT Excluding Unusual Items | -72.78 | -53.59 | -42.21 | -58.32 | -63.66 | |
| Gain (Loss) on Sale of Assets | - | - | - | -0.19 | - | |
| Pretax Income | -72.78 | -53.59 | -42.21 | -58.51 | -63.66 | |
| Net Income | -72.78 | -53.59 | -42.21 | -58.51 | -63.66 | |
| Net Income to Common | -72.78 | -53.59 | -42.21 | -58.51 | -63.66 | |
| Shares Outstanding (Basic) | 67 | 58 | 50 | 34 | 28 | |
| Shares Outstanding (Diluted) | 67 | 58 | 50 | 34 | 28 | |
| Shares Change (YoY) | 15.41% | 17.41% | 46.56% | 21.35% | 20.29% | |
| EPS (Basic) | -1.08 | -0.92 | -0.85 | -1.72 | -2.28 | |
| EPS (Diluted) | -1.08 | -0.92 | -0.85 | -1.72 | -2.28 | |
| Free Cash Flow | -54.44 | -36.47 | -33.16 | -47.41 | -54.53 | |
| Free Cash Flow Per Share | -0.81 | -0.62 | -0.67 | -1.40 | -1.95 | |
| Gross Margin | -54.00% | - | - | - | -38.79% | |
| Operating Margin | -21982.57% | - | - | -8293.86% | -4443.87% | |
| Profit Margin | -20794.57% | - | - | -8357.86% | -4489.42% | |
| Free Cash Flow Margin | -15553.43% | - | - | -6773.43% | -3845.84% | |
| EBITDA | -75.87 | -55.08 | -42.37 | -56.7 | -61.87 | |
| D&A For EBITDA | 1.07 | 1.18 | 1.21 | 1.36 | 1.15 | |
| EBIT | -76.94 | -56.26 | -43.57 | -58.06 | -63.01 | |
| Revenue as Reported | - | - | - | 0.7 | 1.42 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.